Boston prevails in stent patent tussle with Johnson & Johnson
This article was originally published in Clinica
Johnson & Johnson last week suffered a knock-back in an ongoing stent war with rival Boston Scientific when a US district court upheld a July 2005 ruling which found J&J's Cypher drug-eluting stent (DES) to have infringed a Boston patent. Dubbed "Ding", the patent covers a two-layer drug coating technology. Aside from denying J&J's motion to overturn the previous verdict, the court also validated the patent.